Copyright
©The Author(s) 2016.
World J Gastroenterol. Jul 28, 2016; 22(28): 6434-6443
Published online Jul 28, 2016. doi: 10.3748/wjg.v22.i28.6434
Published online Jul 28, 2016. doi: 10.3748/wjg.v22.i28.6434
GBP-1 expression | |
Inflammatory bowel diseases | Expressed in UC and CD[15,20,21] |
Expression in epithelial cells, endothelial cells and immune cells[15,21] | |
Colorectal carcinoma | Expression in the stroma and partially in tumor cells[15,19] |
Associated with Th1-dominated angiostatic micromilieu and improved survival[19,31] | |
Functions of GBP-1 | |
Endothelial cells | Anti-angiogenic, inhibits proliferation, migration, invasion and spreading; protection against apoptosis[16,44,46,47,50] |
Intestinal epithelial cells | Inhibits proliferation; protection against apoptosis[20,43] |
Colon tumor cells | Inhibits proliferation, migration, invasion and tumor growth in vivo; no induction of apoptosis (but partially required)[9] |
T-cells | Inhibition of spreading and early T-cell receptor signaling[54] |
- Citation: Britzen-Laurent N, Herrmann C, Naschberger E, Croner RS, Stürzl M. Pathophysiological role of guanylate-binding proteins in gastrointestinal diseases. World J Gastroenterol 2016; 22(28): 6434-6443
- URL: https://www.wjgnet.com/1007-9327/full/v22/i28/6434.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i28.6434